Syndromic Multiplex Diagnostics Market, By Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Syndromic Multiplex Diagnostics Market size was valued at USD 2,889.76 Million in 2024, expanding at a CAGR of 4.2% from 2024 to 2032.

Syndromic multiplex diagnostics is an advanced diagnostic approach that simultaneously tests for multiple pathogens or biomarkers associated with a specific syndrome using a single test panel. This method integrates molecular techniques, such as PCR, to rapidly identify the causative agents of illnesses with overlapping symptoms like respiratory, gastrointestinal, or neurological infections. By targeting a broad spectrum of pathogens in one test, it enhances diagnostic accuracy, reduces time to treatment, and supports more effective clinical decision-making. This approach is particularly useful in settings where rapid identification of the illness source is critical, such as hospitals, emergency care, and outbreak scenarios.

Syndromic Multiplex Diagnostics Market- Market Dynamics

Rising Demand for Rapid and Accurate Diagnostics

The growing need for fast and precise disease identification is a key driver for the syndromic multiplex diagnostics market. Traditional diagnostic methods are often time-consuming and limited to detecting one pathogen at a time. In contrast, syndromic panels offer quicker turnaround times and the ability to detect multiple pathogens simultaneously from a single sample. This is especially valuable in managing infectious disease outbreaks and in critical care settings, where timely diagnosis can significantly impact patient outcomes. Increased global focus on public health preparedness and antimicrobial stewardship further fuels the demand for such advanced diagnostics.

Syndromic Multiplex Diagnostics Market- Key Insights

According to our research analyst, the global Syndromic Multiplex Diagnostics Market is expected to develop at a CAGR of approximately 4.2% between 2024-2032.

Segmented by Type in 2024, the Respiratory category dominated the market.

Based on End Use, the Hospitals segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Syndromic Multiplex Diagnostics Market- Segmentation Analysis:

The global Syndromic Multiplex Diagnostics Market is divided into Three categories: Type, End-user, and Region.

The syndromic multiplex diagnostics market is segmented by type into Respiratory, Gastrointestinal, Central Nervous System (CNS), and Other Types of Syndromes, which include complicated urinary tract infections (cUTIs) and sexually transmitted diseases (STDs). Among these, the Respiratory segment holds the dominant share of the market. This dominance is primarily driven by the high prevalence of respiratory infections, especially during seasonal flu outbreaks and pandemics such as COVID-19. The need for rapid identification of multiple respiratory pathogens from a single sample enhances clinical efficiency and supports effective infection control measures. Moreover, growing awareness of early diagnosis and increasing adoption of syndromic panels in hospitals and point-of-care settings continue to bolster the demand for respiratory multiplex diagnostic solutions.

By end use, the syndromic multiplex diagnostics market is segmented into Hospitals, Diagnostic Laboratories, and Others, which include clinics, research institutes, and point-of-care settings. Among these, Hospitals represent the dominant segment due to their high patient volume, urgent care requirements, and greater access to advanced diagnostic technologies. Hospitals often deal with complex cases requiring rapid and comprehensive testing, which syndromic panels efficiently provide. The integration of multiplex diagnostics in emergency departments and intensive care units enables timely decision-making and better patient management, especially during infectious disease outbreaks. Additionally, hospitals benefit from in-house laboratories and trained personnel, further supporting the widespread adoption of these technologies for critical syndromic testing applications.

Syndromic Multiplex Diagnostics Market- Geographical Insights

Geographically, the Syndromic Multiplex Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the syndromic multiplex diagnostics market, primarily due to its advanced healthcare infrastructure, strong R&D capabilities, and early adoption of innovative diagnostic technologies. The United States, in particular, leads the region with significant investments in molecular diagnostics and public health initiatives aimed at improving early disease detection. Widespread awareness of infectious diseases, government funding, and well-established reimbursement frameworks further support market growth. Additionally, the high prevalence of respiratory infections and chronic conditions, along with a robust network of hospitals and diagnostic laboratories, reinforces North America's leading role in the global syndromic multiplex diagnostics landscape.

Europe is another leading region in the syndromic multiplex diagnostics market, driven by increasing demand for efficient diagnostic solutions and strong regulatory support for advanced medical technologies. Countries such as Germany, the United Kingdom, and France are at the forefront, benefiting from modern healthcare systems and substantial public health investments. The region's focus on antimicrobial stewardship and infection control has accelerated the adoption of multiplex panels in clinical settings. Moreover, the growing elderly population and rising incidence of respiratory and gastrointestinal infections have further contributed to demand. Europe's commitment to healthcare innovation positions it as a key player in this market.

Syndromic Multiplex Diagnostics Market- Competitive Landscape:

The syndromic multiplex diagnostics market is shaped by established diagnostics giants and innovative newcomers. Leading players such as Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Qiagen, and bioMerieux dominate with comprehensive multiplex panels and advanced molecular platforms. These companies invest heavily in R&D to enhance test accuracy, reduce turnaround times, and expand pathogen coverage. New entrants focus on developing rapid, point-of-care solutions to capture niche markets. Strategic collaborations, mergers, and acquisitions further strengthen market positions. This competitive environment drives continuous innovation, improving diagnostic capabilities and supporting timely, effective patient care worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid multiplex respiratory panel that delivers results in under 30 minutes, enhancing early diagnosis and treatment in clinical settings.

In January 2024, Thermo Fisher expanded its syndromic testing portfolio by acquiring a molecular diagnostics company specializing in automated PCR technologies, boosting its market reach.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd
Qiagen
Biomerieux
Diasorin S.P.A (Luminex Corporation)
Hologic, Inc.
Becton, Dickinson And Company (Bd)
Applied Biocode
Qiagen
Curetis Gmbh
Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

Respiratory
Gastrointestinal
Central Nervous System
Other Types Of Syndromes (Cuti And Stds)

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Laboratories
Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5248

1. Syndromic Multiplex Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Syndromic Multiplex Diagnostics Market Snippet by Type
- 2.1.2. Syndromic Multiplex Diagnostics Market Snippet by End Use
- 2.1.3. Syndromic Multiplex Diagnostics Market Snippet by Country
- 2.1.4. Syndromic Multiplex Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Syndromic Multiplex Diagnostics Key Market Trends

3.1. Syndromic Multiplex Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Syndromic Multiplex Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Syndromic Multiplex Diagnostics Market Opportunities
3.4. Syndromic Multiplex Diagnostics Market Future Trends

4. Syndromic Multiplex Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Syndromic Multiplex Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Syndromic Multiplex Diagnostics Market Landscape

6.1. Syndromic Multiplex Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Syndromic Multiplex Diagnostics Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Respiratory
- 7.1.3. Gastrointestinal
- 7.1.4. Central Nervous System
- 7.1.5. Other Types of Syndromes (cUTI and STDs)

8. Syndromic Multiplex Diagnostics Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Diagnostic Laboratories
- 8.1.4. Others

9. Syndromic Multiplex Diagnostics Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Syndromic Multiplex Diagnostics Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Syndromic Multiplex Diagnostics Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Syndromic Multiplex Diagnostics Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Syndromic Multiplex Diagnostics Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Syndromic Multiplex Diagnostics Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Syndromic Multiplex Diagnostics Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Abbott Laboratories
- 10.2.2. Thermo Fisher Scientific, Inc.
- 10.2.3. F. Hoffmann-La Roche Ltd
- 10.2.4. Qiagen
- 10.2.5. bioMerieux
- 10.2.6. DiaSorin S.p.A (Luminex Corporation)
- 10.2.7. Hologic, Inc.
- 10.2.8. Becton, Dickinson and Company (BD)
- 10.2.9. Applied BioCode
- 10.2.10. QIAGEN
- 10.2.11. Curetis GmbH
- 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us